Comparative Roles of Levofloxacin and Ofloxacin in the Treatment of Multidrug-Resistant Tuberculosis
- 1 October 2003
- Vol. 124 (4) , 1476-1481
- https://doi.org/10.1378/chest.124.4.1476
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Management of Tuberculosis in the United StatesNew England Journal of Medicine, 2001
- The Treatment of Multidrug-Resistant Tuberculosis in TurkeyNew England Journal of Medicine, 2001
- In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacinJournal of Antimicrobial Chemotherapy, 2000
- Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing RegimensChest, 2000
- Moxifloxacin (BAY12-8039), a New 8-Methoxyquinolone, Is Active in a Mouse Model of TuberculosisAntimicrobial Agents and Chemotherapy, 1999
- In-vitro activity of quinolones and macrolides against mycobacteriaJournal of Antimicrobial Chemotherapy, 1994
- Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophagesAntimicrobial Agents and Chemotherapy, 1994
- LevofloxacinDrugs, 1994
- Drug-resistant tuberculosis: laboratory issues: World Health Organization recommendationsTubercle and Lung Disease, 1994
- In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosisJournal of Antimicrobial Chemotherapy, 1990